Yang Zheng

Yang Zheng has a long and varied work experience, beginning with a role as Associate Director at Realty Income Corporation in 2012. Yang then moved to Seurat Therapeutics, Inc. in 2016, where they served as VP of Operations. In 2017, they held roles at Clarix Imaging Corporation as Director of Strategy and Operations, and at Moderne Ventures as Associate. In 2018, they Co-founded Oxalo Therapeutics, Inc. and in 2019 they Co-founded MicroQuin. Currently, they are Head of Business Development at Base4.

Yang Zheng obtained a Master of Business Administration (M.B.A.) from The University of Chicago Booth School of Business with concentrations in Entrepreneurship and Finance. Yang also holds a Bachelor of Arts (B.A.) in Business Economics from University of California, Los Angeles with a minor in Accounting. Yang Zheng began their education at Fudan University.